The Effect of Hydrocortisone on Reducing Rates of Restenosis and Target Lesion Revascularization after Coronary Stenting Less than 3 mm in Stent Diameter
スポンサーリンク
概要
- 論文の詳細を見る
Objective Stenting of small coronary arteries has always been limited by high rates of restenosis, and restenosis has mainly been attributed to inflammatory reactions resulting in cell proliferation and intimal hyperplasia. Based on our experience for several years, we retrospectively investigated the effect of hydrocortisone on reducing in-stent restenosis. Patients and Methods Study population consisted of consecutive 166 patients, 221 lesions, who electively underwent stent implantations stent diameter less than 3 mm into coronary arteries between February 1999 and October 2002. We intravenously administered hydrocortisone before the procedure to 40 patients for preventing allergic reactions due to contrast material, and the effect of hydrocortisone on reducing restenosis was retrospectively compared with 126 patients who did not receive this treatment. Results There was no significant difference in the prevalence of diabetes mellitus, hyperlipidemia, or hypertension between the two groups. There was no significant difference in the type of lesion, length of stent, balloon/artery ratio, or initial success rate between the two groups, but stent diameter was significantly smaller in the hydrocortisone group compared with the control group. On six-month angiographic follow-up, the restenosis rate was significantly lower in the hydrocortisone group compared with the control group (16.2% vs 34.0%, respectively), and the target lesion revascularization rate was also significantly lower in the hydrocortisone group compared with the control group (13.2% vs 27.5%, respectively). Conclusion These results suggest that intravenous administration of hydrocortisone reduces in-stent restenosis of small coronary arteries. Prospectively controlled trials will be necessary to confirm this preventive effect of hydrocortisone.(Internal Medicine 42: 1084-1089, 2003)
著者
-
Sasayama Shigetake
The Department Of Cardiology Hyogo Prefectural Amagasaki Hospital
-
Matsumori Akira
The Department Of Cardiovascular Medicine Kyoto University
-
TAGUCHI Atsushi
The Department of Cardiology, Hamamatsu Rosai Hospital
-
MORITA Yasuhiro
The Department of Cardiology, Hamamatsu Rosai Hospital
-
KAWAMOTO Akira
The Department of Cardiology, Hamamatsu Rosai Hospital
-
KAKIO Tadashi
The Department of Cardiology, Hamamatsu Rosai Hospital
-
OHASHI Naohiro
The Department of Cardiology, Daio Municipal Hospital
-
YAMADA Takehiko
The Department of Cardiology, Daio Municipal Hospital
-
NOBUHARA Mamoru
The Department of Cardiology, Hamamatsu Rosai Hospital
-
SAITO Takeji
The Department of Cardiology, Hamamatsu Rosai Hospital
-
TAKAHASHI Masaaki
The Department of Cardiology, Hamamatsu Rosai Hospital
-
SASAYAMA Shigetake
The Department of Cardiology, Hamamatsu Rosai Hospital
-
MATSUMORI Akira
The Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
関連論文
- PJ-782 In Patients with Heart Failure, Cardiac Troponin T is a Reliable Predictor of Long-Term Echocardiographic Changes and Adverse Cardiac Events(PJ131,Heart Failure (Laboratory/Biomarkers) 2 (M),Poster Session (Japanese),The 73rd Annual Scientific Meet
- PJ-374 In Patients with Advanced Heart Failure, Optimal Outpatient Infusion Therapy May Lower the Length of Hospitalization and Decrease the Cost(PJ063,Heart Failure (Treatment) 1 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Jap
- PJ-344 Who is Suitable for Screening of Silent Coronary Atherosclerosis by 64 Slices-MDCT? : Retrospective Analysis in Asymptomatic 144 Patients(PJ058,CT/MRI (Coronary/Vascular) 1 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Jap
- Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan : Results From Nationwide Surveys
- Effect of Long-Term Cholesterol-Lowering Treatment With HMG-CoA Reductase Inhibitor (Simvastatin) on Myocardial Perfusion Evaluated by Thallium-201 Single Photon Emission Computed Tomography
- Effect of Long-Term Exercise Training on Regional Myocardial Perfusion Changes in Patients With Coronary Artery Disease
- Efficacy of Abciximab for Patients Undergoing Balloon Angioplasty : Data From Japanese Evaluation of c7E3 Fab for Elective and Primary PCI Organization in Randomized Trial (JEPPORT)(Ischemic Heart Disease)
- Treatment of inflammatory cardiomyopathy with immunoglobulin ameriorates ventricular function with suppression of cytokines and oxidative stress
- Evaluation of coronary blood flow reserve by ^N-NH_3 positron emission computed tomography(PET) with dipyridamole in the treatment of hypertention with the ACE inhibitor(Cilazapril)
- Circulating Hepatocyte Growth Factor as a Marker of Thrombus Formation in Unstable Angina Pectoris
- Gene Expression of Cardiac Mast Cell Chymase and Tryptase in a Murine Model of Heart Failure Caused by Viral Myocarditis
- Proinflammatory Cytokine Inhibitor Prolongs the Survival of Rats With Heart Failure Induced by Pressure Overload
- Effects of Exercise Training on Myocardial Fatty Acid Metabolism in Rats With Depressed Cardiac Function Induced by Transient Ischemia
- The Effect of Hydrocortisone on Reducing Rates of Restenosis and Target Lesion Revascularization after Coronary Stenting Less than 3 mm in Stent Diameter
- Pericardial Fluid From Patients With Ischemic Heart Disease Accelerates the Growth of Human Vascular Smooth Muscle Cells
- IS075 Antiviral Effect and Improved Survival by Carvedilol Via Interferon-γ in Heart Failure From Myocarditis
- PJ-515 Anemia is the Predictor of the Elevation of Cardiac Troponin I in Patients with Acute Cardiac Decompensation(Heart failure, clinical(18)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-514 Intermittent Infusion Therapy for Patients with severe chronic heart failure(Heart failure, clinical(18)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-267 Determination of appropriate boundaries of coronary arterial wall by CT density in MDCT ; comparison to IVUS measurement(CT/DSA(08)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Clinical Efficacy and Cost-Benefit Analysis of Nocturnal Home Oxygen Therapy in Patients With Central Sleep Apnea Caused by Chronic Heart Failure
- 5 Cost-Benefit-Analysis of Nocturnal Home-Oxygen-Therapy in Patients with Central Sleep Apnea due to Chronic Heart Failure(Costs of Clinical Practice in Cardiovascular Diseases,Symposium 8 (SY8) (H),The 70th Anniversary Annual Scientific Meeting of the Ja
- Improvement of Quality of Life With Nocturnal Oxygen Therapy in Heart Failure Patients With Central Sleep Apnea
- Effects of the Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms and Functional Capacity in Japanese Patients With Severe Pulmonary Hypertension
- PE-437 Effects of Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms, and Quality of Life in Patients with Severe Pulmonary Hypertension(Pulmonary Circulation 3 (H) : PE74)(Poster Session (English))
- Hepatitis C Virus Infection and Heart Diseases : A Multicenter Study in Japan
- Expression of Heat Shock Protein After Ischemic Preconditioning in Rabbit Hearts
- Cytokine Gene Expression During the Development of Graft Coronary Artery Disease in Mice
- Apical Hypertrophic Cardiomyopathy and Hepatitis C Virus Infection
- Circulating Hepatocyte Growth Factor as an Early Marker of Arterial Thrombus Formation
- IS056 Recombinant hepatocyte growth factor induces capillary endothelial regeneration in a rat model of myocardial ischemia and reperfusion
- Dilated Phase of Hypertrophic Cardiomyopathy With Mid-Ventricular Obstruction After 20-Year Follow-Up
- Measurement of Serum Concentrations of Cardiac Troponin T in Patients with Hypereosinophilic Syndrome : A Sensitive Non-invasive Marker of Cardiac Disorder
- Effects of Nocturnal Oxygen Therapy on Outcome Measures in Patients With Chronic Heart Failure and Cheyne-Stokes Respiration
- 2 Clinical Efficacy and Cost-Benefit-Analysis of Nocturnal Home Oxygen Therapy in Patients with Chronic Heart Failure and Sleep-Disordered Breathing(ESC/JCS Joint Symposium (ESC) (M) : Physical Therapy for Heart Failure)(Special Program)
- A Treatment of Patients with Congestive Heart Failure and Sleep-Disordered Breathing
- Circulating Hepatocyte Growth Factor as a Diagnostic Marker of Thrombus Formation in Patients With Cerebral Infarction
- IS014 Role of Interleukin-10 in a murine model of congestive heart failure induced by viral myocarditis
- IS014 Comparison Between Tagging and Phase Contrast MR Imaging in the Assessment of Regional Myocardial Motion
- Improvement of Regional Myocardial and Coronary Blood Flow Reserve in a Patient Treated With Enhanced External Counterpulsation : Evaluation by Nitrogen-13 Ammonia PET
- Hypertrophic Cardiomyopathy as a Manifestation of Cardiac Sarcoidosis
- High Doses of Digitalis Increase the Myocardial Production of Proinflammatory Cytokines and Worsen Myocardial Injury in Viral Myocarditis : A Possible Mechanism of Digitalis Toxicity
- Interferon Treatment for Dilated Cardiomyopathy and Striated Myopathy Associated With Hepatitis C Virus Infection Based on Serial Measurements of Serum Concentrations of Cardiac Troponin T
- Symposium on Clinical Aspects in Hepatitis Virus Infection, Clinical Practice of Hepatitis: Myocardial Diseases, Nephritis, and Vasculitis Associated with Hepatitis Virus
- Role of Cytokines in the Syndrome of Heart Failure
- Hepatitis C Virus and Cardiomyopathy
- Serial measurements of high sensitive cardiac troponin I in patients with acutely decompensated heart failure treated with carperitide or nitrates
- A Patient With Hypertrophic Cardiomyopathy Accompanied by Right Ventricular Dilation of Unknown Cause
- The Effect of Hydrocortisone on Reducing Rates of Restenosis and Target Lesion Revascularization after Coronary Stenting Less than 3 mm in Stent Diameter